Studies on the structure and catalytic mechanism of huMetAP 2 provide the basis for design and synthesis of new angiogenesis inhibitors.

• 根据甲硫氨酰氨肽酶2的结构以及催化和抑制机制,可以设计和合成新型的血管生成抑制剂;